CAPPED BONUS-ZERTIFIKAT - FRESENIUS MEDICAL CARE Share Price

Certificat

DE000KJ0J2T1

Market Closed - Deutsche Boerse AG 09:10:16 28/06/2024 pm IST
41.69 EUR +0.26% Intraday chart for CAPPED BONUS-ZERTIFIKAT - FRESENIUS MEDICAL CARE
Current month-0.29%
1 month-0.26%
Date Price Change
28/24/28 41.69 +0.26%
27/24/27 41.58 +0.17%
26/24/26 41.51 +0.17%
25/24/25 41.44 -0.36%
24/24/24 41.59 +1.41%

Delayed Quote Deutsche Boerse AG

Last update June 28, 2024 at 09:10 pm IST

More quotes

Static data

Product typeBonus- und Teilschutz-Zertifikate
Buy / SellCALL
Underlying FRESENIUS MEDICAL CARE AG
IssuerLogo Issuer Citi Citi
WKN KJ0J2T
ISINDE000KJ0J2T1
Date issued 10/10/2023
Strike 43.5
Maturity 19/09/2024 (83 Days)
Parity 1 : 1
Emission price 37.83
Emission volume N/A
Settlement Beides
Currency EUR

Technical Indicators

Highest since issue 42.09
Lowest since issue 30.7

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
35.76 EUR
Average target price
39.97 EUR
Spread / Average Target
+11.78%
Consensus